CVE-2022-1731

CVE-2022-1731 is a critical-severity vulnerability in Allgeier Metasonic Doc Webclient with a CVSS 3.x base score of 9.8. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-89.

Key facts

Description

Metasonic Doc WebClient 7.0.14.0 / 7.0.12.0 / 7.0.3.0 is vulnerable to a SQL injection attack in the username field. SSO or System authentication are required to be enabled for vulnerable conditions to exist.

Frequently asked questions

What is CVE-2022-1731?
Metasonic Doc WebClient 7.0.14.0 / 7.0.12.0 / 7.0.3.0 is vulnerable to a SQL injection attack in the username field. SSO or System authentication are required to be enabled for vulnerable conditions to exist.
How severe is CVE-2022-1731?
CVE-2022-1731 has a CVSS 3.x base score of 9.8, rated critical severity. It is exploitable over network with low attack complexity, requires no privileges and no user interaction. Impact on confidentiality is high, integrity high, and availability high.
Is CVE-2022-1731 being actively exploited?
It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (63rd percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2022-1731?
CVE-2022-1731 primarily affects Allgeier Metasonic Doc Webclient. In total, 3 product configurations (CPEs) are listed as vulnerable; see the affected-products list for the exact versions.
How do I fix CVE-2022-1731?
Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its critical severity, prioritise patching exposed systems.
When was CVE-2022-1731 published?
CVE-2022-1731 was published on 2022-05-16 and last updated on 2026-06-17.

References

Affected products (3)

Other CWE-89 (SQL Injection) vulnerabilities

Browse all CWE-89 (SQL Injection) vulnerabilities →